AstraZeneca pledges £650M in UK investments to boost vaccine capabilities, expand near HQ
AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing…
76,750€
-0,32%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca to invest 650 million pounds in UK to boost pandemic preparedness By Reuters
AstraZeneca to invest 650 million pounds in UK to boost pandemic preparedness…
AstraZeneca: Das Jahr 2024 immer noch "relativ katalysatorarm" - Aktienanalyse
New York (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Guggenheim Securities:
Die Analysten von Guggenheim Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…
EMA validates Dato-DXd MAAs for NSQ NSCLC and BC
4 March 2024
Two datopotamab deruxtecan applications validated in the EU for
patients with advanced nonsquamous non-small cell lung
cancer or HR-positive, HER2-negative…
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
U.S. District Judge Colm Connollys decision comes one day before manufacturers have to respond to Medicares initial price offers for…